Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Novo Nordisk buys drug factory in North Carolina for assistance in manufacturing, packaging new diabetes drug

      Novo Nordisk buys drug factory in North Carolina for assistance in manufacturing, packaging new diabetes drug

      Medical Dialogues Bureau7 Aug 2019 9:05 AM IST
      The tablet version of Novo Nordisk diabetes drug, known as semaglutide, is an important growth prospect for the Danish drugmaker, which faces pressure...
      Phase III PARAGON-HF Trial: Novartis announces results of sacubitril-valsartan trial in heart failure patients with preserved ejection fraction

      Phase III PARAGON-HF Trial: Novartis announces results of sacubitril-valsartan trial in heart failure patients with preserved ejection fraction

      Medical Dialogues Bureau6 Aug 2019 5:35 PM IST
      Basel, July 29, 2019 - Novartis announced topline results from the global Phase III PARAGON-HF study, investigating the safety and efficacy of...
      HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials

      HCL Technologies and Oracle Health Sciences Collaborate to Accelerate MHealth in Clinical Trials

      Medical Dialogues Bureau6 Aug 2019 4:37 PM IST
      HCL Technologies (HCL), a leading global technology company and a Platinum-Level member of Oracle Partner Network (OPN), and Oracle Health Sciences...
      Natco Pharma gets EIR from USFDA for Kothur facility

      Natco Pharma gets EIR from USFDA for Kothur facility

      Medical Dialogues Bureau6 Aug 2019 4:35 PM IST
      New Delhi: Drug firm Natco Pharma on Monday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur...
      Ananth Narayanan joins Medlife as co-founder and CEO

      Ananth Narayanan joins Medlife as co-founder and CEO

      Medical Dialogues Bureau6 Aug 2019 4:34 PM IST
      New Delhi: Online health platform Medlife on Monday said former Myntra-Jabong CEO Ananth Narayanan has joined the company as its chief executive...
      Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

      Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India

      Medical Dialogues Bureau5 Aug 2019 10:00 AM IST
      Saroglitazar Magnesium was launched in India during September 2013, under the brand name 'Lipaglyn', for the treatment of hypertriglyceridemia and...
      Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad

      Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad

      Medical Dialogues Bureau5 Aug 2019 9:45 AM IST
      Lupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US...
      Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

      Maharashtra to set up single-window system to grant clearances, address grievances for pharma firms

      Medical Dialogues Bureau5 Aug 2019 9:30 AM IST
      Food and Drug Administration (FDA) Minister Jaykumar Rawal recently held meetings with representatives of the Indian Drug Manufacturing Association to...
      Families say OxyContin maker Purdue Pharma must be held accountable for its role in opioid epidemic

      Families say OxyContin maker Purdue Pharma must be held accountable for its role in opioid epidemic

      Medical Dialogues Bureau5 Aug 2019 9:00 AM IST
      The parents and their supporters rallied outside a Boston courthouse Friday as a judge heard arguments in Massachusetts' lawsuit against Purdue...
      GSK gets European nod for pre-filled pen, syringe Nucala for patients with severe eosinophilic asthma

      GSK gets European nod for pre-filled pen, syringe Nucala for patients with severe eosinophilic asthma

      Medical Dialogues Bureau4 Aug 2019 9:50 AM IST
      UK: GlaxoSmithKline (GSK) recently announced that the European Commission has granted marketing authorization for two new methods of administering...
      Daiichi Sankyo Turalio wins USFDA nod for treatment of rare joint tumour

      Daiichi Sankyo Turalio wins USFDA nod for treatment of rare joint tumour

      Medical Dialogues Bureau4 Aug 2019 9:45 AM IST
      Turalio is the first approved therapy in the United States for TGCT, the primary treatment of which has so far been surgery, the agency said.U.S: The...
      E-cigarette giant Juul Labs campaign donations favour Democrats: Report

      E-cigarette giant Juul Labs campaign donations favour Democrats: Report

      Medical Dialogues Bureau4 Aug 2019 9:15 AM IST
      Juul and cigarette maker Altria — which controls 35 per cent of the vaping company — have backed a Senate bill that raises the age nationally. The...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok